LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai, F Yan… - OncoTargets and …, 2018 - Taylor & Francis
Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …
被引用次数：128 相关文章

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis.

J Quan, X Pan, L Zhao, Z Li, K Dai, F Yan… - Oncotargets and …, 2018 - europepmc.org
Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …
[PDF] scienceopen.com

[PDF][PDF] LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai, F Yan… - OncoTargets and …, 2018 - scienceopen.com
Background: Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai, F Yan… - OncoTargets and …, 2018 - go.gale.com
Background: Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai… - OncoTargets and …, 2018 - search.proquest.com
Background: Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …
[PDF] semanticscholar.org

[PDF][PDF] LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai… - OncoTargets and …, 2018 - pdfs.semanticscholar.org
Background: Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …
[HTML] nih.gov

[HTML][HTML] LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai, F Yan… - OncoTargets and …, 2018 - ncbi.nlm.nih.gov
Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai, F Yan… - OncoTargets and …, 2018 - dovepress.com
Background: Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

J Quan, X Pan, L Zhao, Z Li, K Dai… - OncoTargets and …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis.

J Quan, X Pan, L Zhao, Z Li, K Dai… - OncoTargets & …, 2018 - search.ebscohost.com
Background: Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …